Anxiety Disorders in Children and Adolescent
This event has passed and can no longer be viewed
This event was presented live or live-streamed and has not been designated for on-demand presentation.
Activity Information
Needs Statement
Primary care physicians (PCPs) currently lack appropriate knowledge and competence as it relates to screening, assessment, and provisions of care for youth with mental health disorders. This professional practice gap is largely due to inadequate exposure in medical training and is compounded after training due to inadequate mental health resources such that primary care physicians are frequently the first and only source of assistance for youth and families who are suffering from a mental or behavioral health disorder.
Educational Objectives
At the conclusion of this activity, the participants should be able to:
- List the prevalence, pathogenesis and clinical manifestations of anxiety disorders in youth.
- Recall the recommended evidence based psychotherapy treatment modalities for anxiety disorders in youth.
- Recall the recommended pharmacologic treatment options for youth with moderate to severe anxiety disorders.
Target Audience
Professional Categories
- Physicians
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
Interest Groups
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Directors
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Activity Directors
-
Laurel L Williams, D.O.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.